SK&F's Cefizox (ceftizoxime)
Executive Summary
Third-generation injectable cephalosporin approved by FDA for additional bacterial meningitis indication. Labeling indicates use for meningitis caused by Haemophilus influenzae and notes that Cefizox "has also been used successfully in the treatment of a limited number of pediatric and adult cases of meningitis caused by Streptococcus pneumoniae".